258 related articles for article (PubMed ID: 31283669)
1. Safe Use of Right Lobe Live Donor Livers With up to 20% Macrovesicular Steatosis Without Compromising Donor Safety and Recipient Outcome.
Bhangui P; Sah J; Choudhary N; Gautam D; Gupta V; Srinivasan T; Rastogi A; Piplani T; Saraf N; Saigal S; Soin A
Transplantation; 2020 Feb; 104(2):308-316. PubMed ID: 31283669
[TBL] [Abstract][Full Text] [Related]
2. Use of steatotic graft in living-donor liver transplantation.
Soejima Y; Shimada M; Suehiro T; Kishikawa K; Yoshizumi T; Hashimoto K; Minagawa R; Hiroshige S; Terashi T; Ninomiya M; Shiotani S; Harada N; Sugimachi K
Transplantation; 2003 Jul; 76(2):344-8. PubMed ID: 12883190
[TBL] [Abstract][Full Text] [Related]
3. Graft-to-recipient weight ratio lower to 0.7% is safe without portal pressure modulation in right-lobe living donor liver transplantation with favorable conditions.
Lee SD; Kim SH; Kim YK; Lee SA; Park SJ
Hepatobiliary Pancreat Dis Int; 2014 Feb; 13(1):18-24. PubMed ID: 24463075
[TBL] [Abstract][Full Text] [Related]
4. Right lobe living donors ages 55 years old and older in liver transplantation.
Kim SH; Lee EC; Shim JR; Park SJ
Liver Transpl; 2017 Oct; 23(10):1305-1311. PubMed ID: 28734130
[TBL] [Abstract][Full Text] [Related]
5. [The effect of steatotic donor livers on the prognosis of donors and recipients after pediatric living donor liver transplantation].
Yang Y; Dong C; Sun C; Wang K; Zhang W; Zheng WP; Zhang FB; Qin H; Han C; Wang Z; Xu M; Gao W
Zhonghua Wai Ke Za Zhi; 2022 Oct; 60(10):922-929. PubMed ID: 36207981
[No Abstract] [Full Text] [Related]
6. A graft to body weight ratio less than 0.8 does not exclude adult-to-adult right-lobe living donor liver transplantation.
Selzner M; Kashfi A; Cattral MS; Selzner N; Greig PD; Lilly L; McGilvray ID; Therapondos G; Adcock LE; Ghanekar A; Levy GA; Renner EL; Grant DR
Liver Transpl; 2009 Dec; 15(12):1776-82. PubMed ID: 19938139
[TBL] [Abstract][Full Text] [Related]
7. Readdressing the Middle Hepatic Vein in Right Lobe Liver Donation: Triangle of Safety.
Goja S; Kumar Yadav S; Singh Soin A
Liver Transpl; 2018 Oct; 24(10):1363-1376. PubMed ID: 30359489
[TBL] [Abstract][Full Text] [Related]
8. Safe use of right lobe living donor livers with moderate steatosis in adult-to-adult living donor liver transplantation: a retrospective study.
Yoon YI; Song GW; Lee SG; Park GC; Hwang S; Kim KH; Ahn CS; Moon DB; Ha TY; Jung DH; Kim KW; Shim JH; Tak EY; Kirchner VA; Pruett TL
Transpl Int; 2021 May; 34(5):872-881. PubMed ID: 33660330
[TBL] [Abstract][Full Text] [Related]
9. Living donor liver transplantation in patients weighing ≥100 kg: Low graft weight and obesity do not impact outcomes.
Agarwal S; Goyal N; Nayeem M; Pareek S; Gupta S
Liver Transpl; 2017 Jan; 23(1):35-42. PubMed ID: 27731927
[TBL] [Abstract][Full Text] [Related]
10. Similar outcome after transplantation of moderate macrovesicular steatotic and nonsteatotic livers when the cold ischemia time is kept very short.
Westerkamp AC; de Boer MT; van den Berg AP; Gouw AS; Porte RJ
Transpl Int; 2015 Mar; 28(3):319-29. PubMed ID: 25545740
[TBL] [Abstract][Full Text] [Related]
11. Impact of Graft Selection on Donor and Recipient Outcomes After Living Donor Liver Transplantation.
Braun HJ; Dodge JL; Roll GR; Freise CE; Ascher NL; Roberts JP
Transplantation; 2016 Jun; 100(6):1244-50. PubMed ID: 27123878
[TBL] [Abstract][Full Text] [Related]
12. Unusual grafts for living-donor liver transplantation.
Yim SH; Min EK; Choi MC; Kim DG; Han DH; Joo DJ; Choi JS; Kim MS; Choi GH; Lee JG
Eur J Med Res; 2023 Oct; 28(1):454. PubMed ID: 37875961
[TBL] [Abstract][Full Text] [Related]
13. Excellent outcomes of liver transplantation using severely steatotic grafts from brain-dead donors.
Wong TC; Fung JY; Chok KS; Cheung TT; Chan AC; Sharr WW; Dai WC; Chan SC; Lo CM
Liver Transpl; 2016 Feb; 22(2):226-36. PubMed ID: 26359934
[TBL] [Abstract][Full Text] [Related]
14. Effect of intermittent hepatic inflow occlusion with the Pringle maneuver during donor hepatectomy in adult living donor liver transplantation with right hemiliver grafts: a prospective, randomized controlled study.
Park JB; Joh JW; Kim SJ; Kwon CH; Chun JM; Kim JM; Moon JI; Lee SK
Liver Transpl; 2012 Jan; 18(1):129-37. PubMed ID: 21837746
[TBL] [Abstract][Full Text] [Related]
15. Adult-to-adult living-donor liver transplantation: The experience of the Université catholique de Louvain.
Iesari S; Inostroza Núñez ME; Rico Juri JM; Ciccarelli O; Bonaccorsi-Riani E; Coubeau L; Laterre PF; Goffette P; De Reyck C; Lengelé B; Gianello P; Lerut J
Hepatobiliary Pancreat Dis Int; 2019 Apr; 18(2):132-142. PubMed ID: 30850341
[TBL] [Abstract][Full Text] [Related]
16. Liver regeneration after living donor transplantation: adult-to-adult living donor liver transplantation cohort study.
Olthoff KM; Emond JC; Shearon TH; Everson G; Baker TB; Fisher RA; Freise CE; Gillespie BW; Everhart JE
Liver Transpl; 2015 Jan; 21(1):79-88. PubMed ID: 25065488
[TBL] [Abstract][Full Text] [Related]
17. Clinical implications of preoperative and intraoperative liver biopsies for evaluating donor steatosis in living related liver transplantation.
Jun MJ; Shim JH; Kim SY; Seo N; Kim KM; Lim YS; Lee HC; Yu E; Lee SG
Liver Transpl; 2014 Apr; 20(4):437-45. PubMed ID: 24478019
[TBL] [Abstract][Full Text] [Related]
18. Noninvasive Evaluations to Estimate Graft Steatosis in Living Donor Liver Transplant for Donor Safety and Successful Outcome.
Ahn J; Choi HJ; Park SE; Seo CH; Hong TH; You YK
Transplant Proc; 2022 Mar; 54(2):374-379. PubMed ID: 35090770
[TBL] [Abstract][Full Text] [Related]
19. Donor and recipient outcomes in right lobe adult living donor liver transplantation.
Ghobrial RM; Saab S; Lassman C; Lu DS; Raman S; Limanond P; Kunder G; Marks K; Amersi F; Anselmo D; Chen P; Farmer D; Han S; Durazo F; Goldstein LI; Busuttil RW
Liver Transpl; 2002 Oct; 8(10):901-9. PubMed ID: 12360431
[TBL] [Abstract][Full Text] [Related]
20. Use of severely steatotic grafts in liver transplantation: a matched case-control study.
McCormack L; Petrowsky H; Jochum W; Mullhaupt B; Weber M; Clavien PA
Ann Surg; 2007 Dec; 246(6):940-6; discussion 946-8. PubMed ID: 18043095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
